Categories AlphaGraphs, Earnings, Health Care
AbbVie Q4 2024 adjusted earnings decline despite 6% revenue growth
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced fourth-quarter 2024 financial results, reporting a double-digit dip in adjusted earnings and an increase in revenues.
The company reported worldwide net revenues of $15.1 billion for the December quarter, up 6% from the corresponding period of 2023. The main operating segments registered growth.
Net income, adjusted for special items, declined to $2.16 per share in Q4 from $2.79 per share in the year-ago quarter. On a reported basis, it was a net loss of $22 million or $0.02 per share in the fourth quarter, compared to a profit of $822 million or $0.46 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Fastenal Company likely to report higher Q2 sales and profit
Fastenal Company (NASDAQ: FAST), a leading provider of industrial and construction supplies, is set to publish its second-quarter results next week. The company is among the hardest hit by the
What to look for when Netflix (NFLX) reports its Q2 2025 earnings results
Shares of Netflix, Inc. (NASDAQ: NFLX) stayed red on Monday. The stock has gained 50% over the past three months. The streaming giant is scheduled to report its earnings results
Coinbase shines on stablecoin boom, S&P 500 debut. Will the rally continue?
Coinbase Global, Inc. (NASDAQ: COIN) has emerged as the largest and most user-friendly cryptocurrency exchange in the US, since going public a few years ago. It has played a pivotal
